Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas
Year: 2021
Type: article
Abstract: Deconstructing tissue-specific effects of genes and variants on proliferation is critical to understanding cellular transformation and systematically selecting cancer therapeutics. This requires scalable methods for multiplexed genetic screens tracking fitness across time, across lineages, and in a suitable niche, since physiological cues influence functional differences. Towards this, we present an approach, coupling single-cell cancer driver screens in teratomas with hit enrichment by serial teratoma reinjection, to simultaneously screen drivers across multiple lineages in vivo. Using this system, we analyzed population shifts and lineage-specific enrichment for 51 cancer associated genes and variants, profiling over 100,000 cells spanning over 20 lineages, across two rounds of serial reinjection. We confirmed that c-MYC alone or combined with myristoylated AKT1 potently drives proliferation in progenitor neural lineages, demonstrating signatures of malignancy. Additionally, mutant MEK1 S218D/S222D provides a proliferative advantage in mesenchymal lineages like fibroblasts. Our method provides a powerful platform for multi-lineage longitudinal study of oncogenesis.
Source: iScience
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,000
Awards: G1187008963, G1476237564, G1597182431, Illumina NovaSeq 6000 Sequencing System, Systematic mapping of genetic vulnerabilities in head and neck cancer, Dissecting the interplay of gene regulatory networks and cellular niche on cell fate determination, Next-generation Functional Genetic Screening of Un-screenable Traits, Medical Scientist Training Program, G8841670365, Cancer Center Support Grant (CCSG)
OpenAlex ID: W3201143744
